// April 18, 2024
USP’s commitment to ESG considerations for a healthier, more sustainable world
At the U.S.
At the U.S.
The development of generic versions of innovator medicines is a global public health need.
Generic medicines have benefited millions of Americans and saved trillions of dollars.
The quality of medicine and how it’s delivered to patients is fundamental to treating illness and